Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Press Releases

Evotec AG announced that its multi-target endometriosis alliance with Bayer has advanced a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec. Evotec also announced today that both companies have agreed to extend this multi-target endometriosis alliance until…

Press Releases

Cell & gene therapy continues to be a rapidly emerging and important area of research (by the end of 2015 there were 631 related active clinical trials). With advancements in the area increasing year on year, our annual event offers an opportunity to keep abreast of the latest news and…

Tuesday, Jul 25, 2017
Press Releases

Regenerative medicine or stem cell therapy, as it is more commonly known, encourages us to fully comprehend our body’s regenerative ability. In order to do this, scientists will need to understand both the properties and functions of stem cells. View Agenda >> Our event offers an unparalleled opportunity to gain…

Press Releases

Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated…

Press Releases

Churchill Pharmaceuticals, LLC, a privately held company devoted to expanding treatment options with oral oncology agents, announces that the New Drug Application (NDA) for YONSA™ (abiraterone acetate) ultramicrosize tablets has been accepted for filing by the U.S. Food and Drug Administration (FDA). Under the Prescription Drug User Fee Act (PDUFA),…

Press Releases

Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334 (erenumab) for the prevention of migraine in patients experiencing four or more migraine days per month. If approved, erenumab is expected to be the first and only…

Press Releases

Oxford Global is pleased to share with you the final agenda for our highly anticipated Artificial Intelligence in Drug Development Congress taking place 27 – 28 September 2017 in London. Join us across two days to discuss with over 200 delegates the innovative application of artificial intelligence in drug development…

Press Releases

PersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce its pharmacy credentialing program. The program is available to the more than 4,500 independent pharmacies that participate in the Good Neighbor Pharmacy and Elevate Provider Network programs, and is focused…

Press Releases

Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the first patients have been dosed in the Phase 2a portion of their clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).  The company recently completed the Phase…

Press Releases

Today Lonza announced the release of a new FAQ Tech Tip, “Data Integrity for Endotoxin Testing” for its QC Insider™ Toolbox. Since data integrity is a fundamental component of the pharmaceutical industry, this new support tool will assist QC professionals who are performing bacterial endotoxin testing. Data integrity is the…

loader